Rallybio Corporation
Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a…
Biotechnology
US, New Haven [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Rallybio Corporation can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDRallybio Corporation can't present revenue by segment